Introduction {#s1}
============

Vitamin D is known to be an essential element for bone metabolism and skeletal health. In recent years there has been increasing interest in the influence of vitamin D on extraskeletal health. Indeed, vitamin D status may play a role in diabetes mellitus [@pone.0047264-Pittas1], [@pone.0047264-Svoren1], cancers [@pone.0047264-Garland1], multiple sclerosis [@pone.0047264-Munger1] and other autoimmune diseases [@pone.0047264-Cutolo1], [@pone.0047264-Holick1], cardiovascular diseases [@pone.0047264-Wang1], and infectious diseases [@pone.0047264-Cannell1].

The major source of vitamin D for most humans is exposure to sunlight. Vitamin D3 is synthesized in human skin via the photoisomerization of 7-dehydrocholesterol (7DHC) to yield previtamin D3 during exposure to UVB radiation [@pone.0047264-Webb1]. Previtamin D3 then undergoes hydroxylation in the liver, resulting in the formation of 25-hydroxyvitamin D3 \[25(OH)D3\], the primary circulatory form. 25(OH)D3 subsequently undergoes hydroxylation in the kidney to yield the biologically active form of vitamin D, calcitriol \[1,25-(OH)2D\]. For adults in a bathing suit, exposure to the amount of sunlight that causes a slight pinkness of the skin 24 hours later (1MED) is equivalent to ingesting approximately 20,000 IU of vitamin D [@pone.0047264-Holick1]. Very few foods naturally contain vitamin D, and foods that are fortified with vitamin D are often inadequate to satisfy either a child\'s or an adult\'s vitamin D requirement [@pone.0047264-Holick2].

The serum level of 25(OH)D is a reliable indicator of the vitamin D status of an individual [@pone.0047264-Lips1]. Although vitamin D deficiency has been defined, there is no consensus on a cut-off level for defining vitamin D deficiency. Nevertheless, it is widely suggested that the circulating 25(OH)D concentrations of less than 30 ng/mL should be considered indicative of vitamin D insufficiency, whereas circulating concentrations of less than 20 ng/mL should be considered indicative vitamin D deficiency [@pone.0047264-Chapuy1]. Using these definitions, it has been estimated that between 40% and 100% of elderly US and European non-hospitalized men and women are either vitamin D deficient or insufficient [@pone.0047264-Holick3]. High rates of vitamin D deficiency have been reported in children and adults all over the world [@pone.0047264-Holick4]. Recently, Wat et al. [@pone.0047264-Wat1] have shown that southern Chinese adults exhibit high prevalence (62.8%) of vitamin D insuffficiency \[25(OH)D\<30 ng/mL\] in association with secondary hyperparathyroidism. Zhao et al. [@pone.0047264-Zhao1] showed 25(OH)D was negatively correlated with beta C-terminal cross-linked telopeptides of type I collagen (β-CTX) and amino-terminal propeptide of type I collagen (P1NP) in Chinese postmenopausal women from Beijing. China covers a large area and regions at different latitudes receive different amounts of sunlight. Shanghai, located on the eastern coast of China with a subtropical latitude of 31°N, is a flourishing international metropolis with a population of over 30 million. There is a lack of large-scale studies on vitamin D status and its relationship to parathyroid hormone (PTH) and bone turnover markers in adults living in Shanghai. Therefore, the objectives of our study were to determine the prevalence of vitamin D insufficiency in Shanghai, and to investigate the relationship between 25(OH)D and both parathyroid function and bone turnover markers.

Methods {#s2}
=======

Study population {#s2a}
----------------

From February 2009 to March 2009, 2243 women (aged 20--96 years) and 865 men (aged 23--94 years) - a total of 3,108 healthy Chinese people living in Shanghai - were recruited from several community centers. The study subjects were identical to those included in the Shanghai Osteoporosis Study (SOS). The present study assessed the physical health of the participants, including heart, liver, kidney, and bone health. The study subjects were randomly recruited from among the inhabitants of ten communities of Shanghai according to population composition. We included persons who were confirmed to be living in Shanghai for at least 5 years and listed in the residential registration record. After stratifying the population of each selected community by age, we randomly sampled subjects. Selected participants were called and persuaded to participate in this study. All subjects who agreed to participate in this study were asked to visit an outpatient clinic at the Department of Osteoporosis and Bone Diseases, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital. All participants were of Han ethnicity. Age, body weight, height, and age of menarche and amenorrhea were recorded. All subjects were medically examined and interviewed using a standardized questionnaire to collect information on life style, smoking habits, the level of physical activity during leisure time, and use of vitamins and medications. Dietary calcium intake was calculated using a three food questionnaire.

All subjects were subjected to blood counts, fasting plasma glucose tests, liver and kidney function tests. All healthy subjects included in the present study had (1) normal blood counts and (2) normal results for liver and kidney function tests. In addition, no participant was receiving treatment or had medical complications known to affect bone metabolism, including cancer, hyperthyroidism, diabetes mellitus, primary hyperparathyroidism, pituitary, adrenal and rheumatic diseases. Participants who had taken vitamin D and/or calcium supplements within 3 months were also excluded.

The study was approved by the Ethics Committee of the Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital. All participants signed informed consent forms before entering the study.

Blood collection and analysis {#s2b}
-----------------------------

Fasting blood samples were collected for the measurement of the serum levels of calcium, phosphate, albumin, glucose, insulin, cholesterol, triglycerides (TG), blood urea nitrogen (BUN), creatinine (Cr), alanine aminotransferase (ALT), aspartate transaminase (AST), r-glutamyl transpeptidase (r-GT), alkaline phosphatase (ALP), intact parathyroid hormone (iPTH), beta C-terminal cross-linked telopeptides of type I collagen (β-CTX), amino-terminal propeptide of type I collagen (P1NP), osteocalcium (OC) and 25-hydroxyvitamin D \[25(OH)D\]. Serum levels of 25(OH)D, PTH, β-CTX, intact-OC, and P1NP were determined using an ECLIA Elecsys autoanalyzer (E170; Roche Diagnostic GmbH, Mannheim, Germany). The intra-assay coefficients of variation (CVs) for 25(OH)D were 5.7% at a level of 25.2 ng/mL, 5.7% at a level of 39.9 ng/mL and 5.4% at a level of 65.6 ng/mL, respectively. The inter-assay CVs for 25(OH)D were 9.9% at a level of 25.2 ng/mL, 7.3% at a level of 39.9 ng/mL and 6.9% at a level of 65.6 ng/mL, respectively. The lower limit of detection of 25(OH)D was \<4 ng/mL (10 mmol/L). The intra-assay and inter-assay CVs were 1.4% and 2.9%, respectively, for PTH, 2.5% and 3.5%, respectively, for β-CTX, 2.9% and 4.0%, respectively, for OC, and 2.3% and 2.8%, respectively, for P1NP. All serum samples were taken during the winter season (from February 2009 to March 2009).

Statistical analysis {#s2c}
--------------------

Continuous variables are presented as means (±SD). Data that are not normally distributed are shown as medians and inter-quartile ranges (in parentheses). Results that were not normally distributed were log transformed before analysis. Student\'s t-test was used to compare the mean values of continuous variables. Because of sex interactions, we analyzed the data separately for men and women. Circulating 25(OH)D concentrations were divided into four subgroups according to the following criteria: severely deficient (\<10 ng/mL), deficient (≥10 and \<20 ng/mL), insufficient (≥20 and \<30 ng/mL), and sufficient (≥30 ng/mL). ANOVA was used to assess differences in age, BMI and the levels of serum PTH, bone turnover markers, and albumin among different 25(OH)D subgroups. Pairwise comparisons for multiple comparisons (Bonferroni) were also performed if the one-way ANOVA was significant. Locally weighted regression smoothing (LOESS) plots were performed to study the correlation of 25(OH)D with PTH and bone turnover markers. Potential confounders included age and BMI. First, unadjusted analyses were performed. Subsequently, potential confounders were added to the methods. All calculations were performed using SPSS ver. 11.0 (SPSS Inc., Chicago, IL, USA). Results were regarded as statistically significant at a value of p\<0.05.

Results {#s3}
=======

Based on the results of the biochemical tests, physical examinations and detailed questionnaires, we excluded 404 females and 216 males. Finally, 1839 women and 649 men were included. The clinical characteristics and mean laboratory values of the 1839 women and 649 men, aged 20--89 years, are shown in [Table 1](#pone-0047264-t001){ref-type="table"}. All participants were of Han ethnicity and residents of Shanghai. The overall median (inter-quartile range) serum concentrations of 25(OH)D, PTH, β-CTX, OC and P1NP were 20.9 (16.9--25.0) ng/mL, 33.7 (26.3--43.6) pg/mL, 320.0 (220.0--460.0) pg/mL, 17.5 (13.6--23.0) ng/mL, and 39.9 (30.7--53.2) ug/L, respectively. On average, men had significantly higher 25(OH)D and β-CTX concentrations and lower PTH concentrations than women. The concentrations of OC (*p* = 0.307) and P1NP (*p* = 0.961) did not differ significantly between males and females. Age was negatively correlated with the levels of β-CTX (*r* = −0.224; *p*\<0.001) and P1NP (*r* = −0.228; *p*\<0.001) in men, while it was positively correlated with the levels of β-CTX (*r* = 0.211; *p*\<0.001) and OC (*r* = 0.282; *p*\<0.001) in women. The levels of 25(OH)D, PTH, and other bone turnover markers were not significantly correlated with age in both genders.

10.1371/journal.pone.0047264.t001

###### Clinical and laboratory characteristics.

![](pone.0047264.t001){#pone-0047264-t001-1}

                     Total sample (n = 2588)     Women (n = 1939)        Men (n = 649)       *p* value
  ----------------- ------------------------- ---------------------- ---------------------- -----------
  Age (years)               43.0±15.7               42.2±15.9              45.5±14.8          \<0.001
  20--35 years             829 (32.0%)             636 (32.8%)            193 (29.7%)       
  36--50 years             793 (30.6%)             586 (30.2%)            207 (31.9%)       
  ≥51 years                966 (37.3%)             717 (37.0%)            249 (38.4%)       
  BMI                       22.9±8.6                 22.2±9.7               24.8±3.5          \<0.001
  Albumin (g/L)             50.1±2.6                 49.9±2.6               50.6±2.5          \<0.001
  25(OH)D (ng/mL)       20.9 (16.9--25.0)       20.1 (16.2--24.3)      22.8 (19.1--27.0)      \<0.001
  PTH (pg/mL)           33.7 (26.3--43.6)       34.4 (27.1--44.0)      31.4 (24.4--41.9)      \<0.001
  β-CTX (pg/mL)       320.0 (220.0--460.0)     310.0 (210.0--440.0)   370.0 (260.0--512.5)    \<0.001
  OC (ng/mL)            17.5 (13.6--23.0)       17.5 (13.5--23.2)      17.2 (13.8--22.0)       0.307
  P1NP (µg/L)           39.9 (30.7--53.2)       39.9 (30.5--53.6)      39.9 (31.0--52.5)       0.961

Notes: Normally distributed data are shown as mean ± standard. Data that are not normally distributed are shown as medians and inter-quartile ranges (in parentheses).

25(OH)D concentrations were divided into four subgroups according to the following criteria: severely deficient (\<10 ng/mL), deficient (≥10 and \<20 ng/mL), insufficient (≥20 and \<30 ng/mL), and sufficient (≥30 ng/mL). The prevalence of vitamin D insufficiency was 84% in males and 89% in females. The prevalence of vitamin D deficiency was 30% in males and 46% in females. The prevalence of severe vitamin D deficiency was 2% in males and 3.6% in females. The 25(OH)D concentration in men over 60 years was (22.93±7.43) ng/mL, whereas it was (23.91±7.39) ng/mL in those under 60 years. The vitamin D concentration in women over 50 years was (22.70±6.93) ng/mL, whereas it was (20.72±6.91) ng/mL in those under 50 years. There was no significant difference between different age groups for either sex. Because of sex interactions, we analyzed the data separately for males and females. In females (as shown in [Table 2](#pone-0047264-t002){ref-type="table"}), in subgroups with increasing mean 25(OH)D levels, the mean PTH level deceased (by ANOVA, *p*\<0.001). In addition, the levels of bone turnover markers, including β-CTX, OC and P1NP, decreased with increasing serum 25(OH)D concentrations (by ANOVA, *p*\<0.001). These correlations persisted even after adjustment for age and BMI. In males (as shown in [Table 3](#pone-0047264-t003){ref-type="table"}), in subgroups with increasing mean 25(OH)D concentrations, the mean PTH concentration decreased (by ANOVA, *p*\<0.001). In addition, the levels of bone turnover markers, including β-CTX, OC and P1NP, decreased with increasing serum 25(OH)D concentrations (by ANOVA, *p*\<0.05). These correlations (except β-CTX: *p* = 0.249 and P1NP: *p* = 0.065) persisted after adjustment for age and BMI.

10.1371/journal.pone.0047264.t002

###### Differences in the levels of bone turnover markers in females in different serum 25(OH)D level groups.

![](pone.0047264.t002){#pone-0047264-t002-2}

  Parameter                                    Serum 25(OH)D concentration (ng/mL)                                                                                                                                                                 
  ----------------- ----------------------------------------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------------- ---------
  n                                                            91                                                                       852                                                      850                                   146         
  Age (years)                                               43.1±16.9                                                                41.7±15.8                                                42.1±16.0                             44.6±15.1        0.209
  BMI                                                       21.1±2.4                                                                  21.9±3.6                                                 22±2.8                               22.3±2.6         0.261
  Albumin (g/L)                                             49.9±2.6                                                                   50±2.6                                                 49.9±2.5                                50±3           0.731
  25(OH)D (ng/mL)                                        7.5 (4.0--8.9)                                                          16.5 (14.2--18.3)                                         23.4 (21.6--26)                      33.3 (31.4--35.7)   \<0.001
  PTH (pg/mL)        38.7 (30.2--49.9)[\*\*\*](#nt103){ref-type="table-fn"} [&](#nt105){ref-type="table-fn"}   35.4 (28.7--45.1)[\*\*\*](#nt103){ref-type="table-fn"}   33.4 (26.6--43.1) [\*\*](#nt104){ref-type="table-fn"}    29 (21.4--39.1)    \<0.001
  β-CTX (pg/mL)                        350 (240--490)[\*\*\*](#nt103){ref-type="table-fn"}                     325 (222.5--470)[\*\*\*](#nt103){ref-type="table-fn"}                       290 (190--420)                        270 (180--435)     \<0.001
  OC (ng/mL)                         18.6 (15.1--28.5)[\*\*\*](#nt103){ref-type="table-fn"}                    18.8 (14.5--24.8)[\*\*\*](#nt103){ref-type="table-fn"}   16.7 (12.9--21.9)[\*\*](#nt104){ref-type="table-fn"}    15.3 (11.4--20.5)   \<0.001
  P1NP (µg/L)                        42.0 (33.2--63.9)[\*\*\*](#nt103){ref-type="table-fn"}                    41.9 (32.6--55.3)[\*\*\*](#nt103){ref-type="table-fn"}   38.3 (29.5--51.5)[\*\*](#nt104){ref-type="table-fn"}    34.9 (25.2--46.9)   \<0.001

Notes: Normally distributed data are shown as mean ± standard. Data that are not normally distributed are shown as medians and inter-quartile ranges (in parentheses).

*p*\<0.001 vs. 20--30 ng/mL and \>30 ng/mL.

*p*\<0.01 vs. \>30 ng/mL.

*p*\<0.05 vs. 10--20 ng/mL.

10.1371/journal.pone.0047264.t003

###### Differences in the values of bone turnover markers in males with different levels of serum 25(OH)D.

![](pone.0047264.t003){#pone-0047264-t003-3}

                                               Serum 25(OH)D concentration (ng/mL)                                                                                                                               
  ----------------- ----------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------- -------------------- ---------
  n                                                            19                                                                        181                                    366                  83          
  Age (years)                                               41.1±17.2                                                                 47.8±16.1                               44.4±14            46.3±14.3         0.041
  BMI                                                       22.5±2.6                                                                  25.2±3.3                               24.8±3.7             24.2±2.8         0.077
  Albumin (g/L)                                             50.1±2.9                                                                  50.3±2.4                               50.7±2.7             50.7±2.1         0.485
  25(OH)D (ng/mL)                                         7.7 (4--8.6)                                                            17.6 (16.1--18.9)                      24.2 (22.2--26.6)   34.2 (32.4--39.6)   
  PTH (pg/mL)        41.8 (34.9--58.2)[\*\*\*](#nt107){ref-type="table-fn"} [&](#nt109){ref-type="table-fn"}   33.5 (25.7--46.1) [\*\*\*](#nt107){ref-type="table-fn"}   30.4 (24.3--40.8)   27.4 (21.1--38.2)    \<0.001
  β-CTX (pg/mL)       470 (320--730)[\*\*\*](#nt107){ref-type="table-fn"} [&](#nt109){ref-type="table-fn"}                         390 (280--530)                         370 (260--510)     325 (232.5--472.5)    0.014
  OC (ng/mL)          23 (16.8--26.9)[\*\*\*](#nt107){ref-type="table-fn"} [&](#nt109){ref-type="table-fn"}      18.4 (14--24) [\*\*\*](#nt107){ref-type="table-fn"}      17 (12.5--21.4)     16 (13.8--19.4)      0.001
  P1NP (µg/L)                         53 (37.6--67.1)[\*\*\*](#nt107){ref-type="table-fn"}                      42.4 (32.5--54.2) [\*\*](#nt108){ref-type="table-fn"}      39 (30.5--52)     38.3 (29.5--47.5)     0.002

Notes: Normally distributed data are shown as mean ± standard. Data that are not normally distributed are shown as medians and inter-quartile ranges (in parentheses).

*p*\<0.005 vs. 20--30 ng/mL and \>30 ng/mL.

*p*\<0.05 vs. \>30 ng/mL.

*p*\<0.05 vs. 10--20 ng/mL.

The 25(OH)D level were significantly correlated with the levels of PTH (*r* = −0.139; *p* = 0.035), OC (*r* = −0.188; *p* = 0.004) and P1NP (*r* = −0.146; *p* = 0.025), but not with β-CTX (*r* = −0.083; *p* = 0.206) in males after adjustment for age and BMI. In [Fig. 1](#pone-0047264-g001){ref-type="fig"}, the LOESS plots, adjusted for age and BMI, show the mean value of the serum levels of PTH and bone turnover makers for each level of serum 25(OH)D. In the inverse relationship between the serum 25(OH)D and PTH levels ([Fig. 1a](#pone-0047264-g001){ref-type="fig"}), there was a relatively steep decrease in PTH up to 20 ng/mL and a relatively slow decrease between 20 and 40 ng/mL. This relationship between the serum 25(OH)D and PTH levels exhibited no plateau with increasing serum 25(OH)D levels up to 40 ng/mL. LOESS plots for the relationships between the serum levels of 25(OH)D and bone turnover markers including β-CTX ([Fig. 1b](#pone-0047264-g001){ref-type="fig"}), OC ([Figure 1c](#pone-0047264-g001){ref-type="fig"}) and P1NP ([Fig. 1d](#pone-0047264-g001){ref-type="fig"}) exhibit plateau concentrations of bone turnover markers; these plateaus occur at a 25(OH)D level of approximately 30 ng/mL. When the serum 25(OH)D concentrations are below 30 ng/mL the levels of bone turnover markers begin to increase. The 25(OH)D level were significantly correlated with the levels of PTH (*r* = −0.188; *p*\<0.001), β-CTX (*r* = −0.104; *p* = 0.005), OC (*r* = −0.172; *p*\<0.001) and P1NP (*r* = −0.107; *p* = 0.004) in females after adjustment for age and BMI. [Fig. 2](#pone-0047264-g002){ref-type="fig"} shows the correlations of the 25(OH)D levels with the levels of PTH and bone turnover markers in females. An inverse relationship between the serum 25(OH)D and PTH levels ([Fig. 2a](#pone-0047264-g002){ref-type="fig"}) was observed, with a gradual decrease up to 40 ng/mL. This relationship between the serum 25(OH)D and PTH levels exhibited no plateau for serum 25(OH)D levels up to 40 ng/mL. In addition, the LOESS plots for the relationships between the levels of 25(OH)D and bone turnover markers including β-CTX ([Fig. 2b](#pone-0047264-g002){ref-type="fig"}), OC ([Fig. 2c](#pone-0047264-g002){ref-type="fig"}) and P1NP ([Fig. 2d](#pone-0047264-g002){ref-type="fig"}) show inverse relationships between the levels of 25(OH)D and those of bone turnover markers, but no plateau was observed for serum 25(OH)D levels up to 40 ng/mL.

![Relationships between the serum 25(OH)D concentration and the concentrations of PTH and bone turnover markers in males.\
(A) PTH. There was a relatively steep decrease in the concentration of PTH up to 20 ng/mL 25(OH)D and a more gradual decrease between 20 and 40 ng/mL 25(OH)D. This relationship between the serum concentrations of 25(OH)D and PTH exhibited no plateau for serum 25(OH)D levels up to 40 ng/mL. (B--D) β-CTX, OC, and P1NP, respectively. LOESS plots show the plateau levels of bone turnover markers and the 25(OH)D level at which these plateaus are reached, corresponding to 30 ng/mL. When the serum 25(OH)D levels are lower than 30 ng/mL, the levels of the bone turnover markers begin to increase.](pone.0047264.g001){#pone-0047264-g001}

![Relationships between serum 25(OH)D concentration and the concentrations of PTH and bone turnover markers in females.\
(A) PTH. The inverse relationship between the serum concentrations of 25(OH)D and PTH was observed with a gradual decrease up to 40 ng/mL. This relationship between the serum concentrations of 25(OH)D and PTH exhibited no plateau for serum 25(OH)D levels up to 40 ng/mL. (B--D) β-CTX, OC, and P1NP, respectively. LOESS plots show an inverse relationship between the serum concentration of 25(OH)D and bone turnover markers, but no plateau was observed for serum 25(OH)D levels up to 40 ng/mL.](pone.0047264.g002){#pone-0047264-g002}

Discussion {#s4}
==========

Shanghai is located on the eastern coast of China, with a subtropical latitude of 31°N, where vitamin D deficiency was assumed not to be a clinical problem due to the abundant sunshine. However, the results of the present study challenge this assumption. The present study clearly demonstrated that there is a high prevalence of vitamin D insufficiency and/or deficiency among healthy adults living in Shanghai during the winter season. During the winter, the zenith angle is increased, and UVB photons are absorbed by the earth\'s ozone layer. In addition, this population has a low vitamin D intake because food in China is not supplemented with vitamin D. The results of the present study, together with previous results for Caucasians [@pone.0047264-Chapuy1], [@pone.0047264-Lips2]--[@pone.0047264-vanDam1], Asians [@pone.0047264-Holick4], [@pone.0047264-Goswami1]--[@pone.0047264-HoPham1], and other men [@pone.0047264-Meddeb1], confirm the observation that vitamin D deficiency and/or insufficiency is endemic among populations around the world.

There is still no consensus on the serum 25(OH)D level that defines optimal vitamin D status. However, it is generally agreed that a functional rather than an epidemiological definition should be adopted because serum 25(OH)D concentrations vary with sunshine exposure, season and diet. The proposed criteria to define an optimal level of 25(OH)D include maximum suppression of circulating PTH concentrations, maximum calcium absorption, high bone mineral density, and reduced fracture rates [@pone.0047264-Heaney1], [@pone.0047264-McKenna1]. In agreement with previous studies [@pone.0047264-Ardawi1], [@pone.0047264-Souberbielle1], [@pone.0047264-Pepe1], the present study describes a significant inverse relationship between the serum 25(OH)D and PTH levels independent of age and BMI. This result suggests that vitamin D sufficiency can maintain low serum PTH values. However, although there was a negative correlation between the serum 25(OH)D and PTH levels, there was no threshold values for serum 25(OH)D at which the PTH concentration plateaued at 25(OH)D concentrations less than 40 ng/mL in either males or females. This result was consistent with some studies [@pone.0047264-Harinarayan1], [@pone.0047264-Ardawi1], [@pone.0047264-HoPham1], but not all [@pone.0047264-Chapuy1], [@pone.0047264-Saliba1].

The role of vitamin D in the maintenance of bone health is well documented in various populations. However, there is a controversy regarding the relationship between vitamin D and bone turnover markers. Garnero et al. [@pone.0047264-Garnero1] have indicated that vitamin D is unlikely to play a major role in regulating the systemic levels of bone turnover markers. In the present study, as reported in several previous studies [@pone.0047264-GannageYared1], [@pone.0047264-Diamond1], we found a significant inverse correlation between the serum levels of 25(OH)D and bone turnover markers, independent of age and BMI. These data suggest that vitamin D insufficiency may be related to accelerated bone turnover, and subsequently, osteoporosis. Several studies [@pone.0047264-Holick4], [@pone.0047264-Visser1], [@pone.0047264-Sambrook1] have indicated that secondary parathyroidism associated with vitamin D insufficiency is the cause of increased bone resorption, falls and osteoporotic fracture. Allali et al. [@pone.0047264-Allali1] showed that the correlation between osteocalcin and 25(OH)D is independent of PTH. These findings suggest that vitamin D insufficiency might contribute both directly and indirectly via secondary parathyroidism to accelerated bone turnover. The present study showed that when the serum 25(OH)D concentrations were below 30 ng/mL, the levels of bone turnover markers began to increase in males. The different cutoff points for the serum 25(OH)D level as a marker of the levels of PTH and bone turnover markers seem to paint a biochemical picture in which vitamin D may influence bone turnover directly and indirectly via PTH. When the serum 25(OH)D concentration is below 20 ng/mL, the decrease in the level of serum 25(OH)D will cause a rapid increase in PTH. So, we strongly recommend taking calcium and vitamin D supplements when the serum 25(OH)D concentration is below 20 ng/mL. In addition, for the appropriate maintenance of bone turnover, a level of serum 25(OH)D of 30 ng/mL is suggested. Furthermore, the different cutoff points for serum 25(OH)D as a marker of the levels of PTH and bone turnover markers demonstrate that serum 25(OH)D can influence bone turnover through a new mechanism that is independent of PTH. Therefore, further studies aiming to elucidate the underlying mechanism are needed. Similarly, inverse correlations of serum 25(OH)D with PTH and bone turnover markers were also observed in females (as shown in [Fig. 2](#pone-0047264-g002){ref-type="fig"}). However, there were no obvious cutoff points for the serum 25(OH)D concentration associated with appropriate levels of PTH and bone turnover markers. This result might be related to the sex difference and to the fact that serum PTH level is regulated by several other factors including calcium intake.

Secondary hyperparathyroidism results not only from vitamin D deficiency, but also from low calcium intake and low calcium absorption. Similar to other studies [@pone.0047264-Holick4], [@pone.0047264-Ardawi1] conducted in Asian populations, the mean dietary calcium intake of the subjects in the present study was low at (606±232) mg/day. Low dietary calcium intake may contribute to the changes in the serum PTH responses to changes in serum 25(OH)D levels. Therefore, it is important to recommend the use of both vitamin D and calcium supplements.

The strengths of the present study include its large sample size with very strict detailed inclusion criteria. The study population is highly homogeneous, which reduces the effects of potential ethnic and regional confounders that could compromise the estimates. In addition, this study was a population-based study, such that the results can be generalized to all healthy Shanghai adults. The main limitation of the present study was its cross-sectional design; hence, no causal inferences could be made for the observed relations between factors. The participants in this study were sampled from several community centers, and therefore, the selection bias may have been related to the fact that healthy individuals were more likely to participate in the study. In addition, the Roche Elecsys Vitamin D3 (25-OH) immunoassay may overestimate the number of patients with vitamin D deficiency [@pone.0047264-Connell1].

In conclusion, vitamin D deficiency/insufficiency is very common (30% of men and 46% of women with vitamin D below 20 ng/mL; 84% of men and 89% of women with vitamin D below 30 ng/mL) among healthy adults living in Shanghai. Low serum 25(OH)D levels were associated with both secondary hyperthyroidism and high bone turnover status. Further studies aiming to elucidate the underlying mechanism by which serum 25(OH)D affects bone turnover are needed.
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